nodes	percent_of_prediction	percent_of_DWPC	metapath
Desogestrel—PGR—breast cancer	0.129	0.39	CbGaD
Desogestrel—SHBG—breast cancer	0.12	0.364	CbGaD
Desogestrel—SHBG—Fluoxymesterone—breast cancer	0.0941	0.264	CbGbCtD
Desogestrel—Danazol—Fluoxymesterone—breast cancer	0.0856	0.535	CrCrCtD
Desogestrel—ESR1—breast cancer	0.0814	0.246	CbGaD
Desogestrel—Norethindrone—Fluoxymesterone—breast cancer	0.0745	0.465	CrCrCtD
Desogestrel—ESR1—Fluoxymesterone—breast cancer	0.0681	0.191	CbGbCtD
Desogestrel—ESR1—Toremifene—breast cancer	0.0681	0.191	CbGbCtD
Desogestrel—ESR1—Fulvestrant—breast cancer	0.0633	0.178	CbGbCtD
Desogestrel—ESR1—Raloxifene—breast cancer	0.0376	0.106	CbGbCtD
Desogestrel—ESR1—Tamoxifen—breast cancer	0.0249	0.0698	CbGbCtD
Desogestrel—PGR—corpus luteum—breast cancer	0.00768	0.303	CbGeAlD
Desogestrel—PGR—mammary gland—breast cancer	0.00119	0.0469	CbGeAlD
Desogestrel—PGR—nipple—breast cancer	0.000985	0.0388	CbGeAlD
Desogestrel—ESR1—mammary gland—breast cancer	0.000931	0.0367	CbGeAlD
Desogestrel—PGR—epithelium—breast cancer	0.000663	0.0261	CbGeAlD
Desogestrel—SHBG—endometrium—breast cancer	0.00066	0.026	CbGeAlD
Desogestrel—ESR1—embryo—breast cancer	0.000636	0.0251	CbGeAlD
Desogestrel—SHBG—uterus—breast cancer	0.000608	0.024	CbGeAlD
Desogestrel—SHBG—pituitary gland—breast cancer	0.000597	0.0235	CbGeAlD
Desogestrel—SHBG—adipose tissue—breast cancer	0.000595	0.0235	CbGeAlD
Desogestrel—PGR—endometrium—breast cancer	0.000595	0.0234	CbGeAlD
Desogestrel—PGR—uterus—breast cancer	0.000548	0.0216	CbGeAlD
Desogestrel—SHBG—female reproductive system—breast cancer	0.000547	0.0216	CbGeAlD
Desogestrel—PGR—pituitary gland—breast cancer	0.000538	0.0212	CbGeAlD
Desogestrel—PGR—adipose tissue—breast cancer	0.000536	0.0211	CbGeAlD
Desogestrel—SHBG—adrenal gland—breast cancer	0.000534	0.021	CbGeAlD
Desogestrel—ESR1—epithelium—breast cancer	0.000519	0.0204	CbGeAlD
Desogestrel—SHBG—bone marrow—breast cancer	0.000516	0.0204	CbGeAlD
Desogestrel—SHBG—female gonad—breast cancer	0.000498	0.0196	CbGeAlD
Desogestrel—PGR—female reproductive system—breast cancer	0.000493	0.0194	CbGeAlD
Desogestrel—PGR—adrenal gland—breast cancer	0.000481	0.0189	CbGeAlD
Desogestrel—ESR1—endometrium—breast cancer	0.000465	0.0183	CbGeAlD
Desogestrel—SHBG—endocrine gland—breast cancer	0.000463	0.0182	CbGeAlD
Desogestrel—PGR—female gonad—breast cancer	0.000448	0.0177	CbGeAlD
Desogestrel—ESR1—uterus—breast cancer	0.000429	0.0169	CbGeAlD
Desogestrel—ESR1—pituitary gland—breast cancer	0.000421	0.0166	CbGeAlD
Desogestrel—ESR1—adipose tissue—breast cancer	0.000419	0.0165	CbGeAlD
Desogestrel—PGR—endocrine gland—breast cancer	0.000417	0.0164	CbGeAlD
Desogestrel—ESR1—female reproductive system—breast cancer	0.000385	0.0152	CbGeAlD
Desogestrel—ESR1—adrenal gland—breast cancer	0.000376	0.0148	CbGeAlD
Desogestrel—ESR1—female gonad—breast cancer	0.000351	0.0138	CbGeAlD
Desogestrel—ESR1—endocrine gland—breast cancer	0.000326	0.0129	CbGeAlD
Desogestrel—PGR—lymph node—breast cancer	0.000288	0.0114	CbGeAlD
Desogestrel—ESR1—lymph node—breast cancer	0.000225	0.00888	CbGeAlD
Desogestrel—Allylestrenol—PGR—breast cancer	0.00019	0.0647	CrCbGaD
Desogestrel—Norelgestromin—PGR—breast cancer	0.00019	0.0647	CrCbGaD
Desogestrel—Norgestimate—PGR—breast cancer	0.000171	0.0582	CrCbGaD
Desogestrel—Quinestrol—ESR1—breast cancer	0.000154	0.0525	CrCbGaD
Desogestrel—Etonogestrel—PGR—breast cancer	0.000148	0.0504	CrCbGaD
Desogestrel—Etonogestrel—SHBG—breast cancer	0.000138	0.0471	CrCbGaD
Desogestrel—Allylestrenol—ESR1—breast cancer	0.00012	0.0408	CrCbGaD
Desogestrel—Mestranol—ESR1—breast cancer	0.000117	0.0398	CrCbGaD
Desogestrel—Norgestimate—ESR1—breast cancer	0.000108	0.0368	CrCbGaD
Desogestrel—Levonorgestrel—PGR—breast cancer	0.000105	0.0356	CrCbGaD
Desogestrel—Levonorgestrel—SHBG—breast cancer	9.78e-05	0.0333	CrCbGaD
Desogestrel—Danazol—PGR—breast cancer	9.53e-05	0.0325	CrCbGaD
Desogestrel—Etonogestrel—ESR1—breast cancer	9.34e-05	0.0318	CrCbGaD
Desogestrel—Ethinyl Estradiol—ESR2—breast cancer	9.04e-05	0.0308	CrCbGaD
Desogestrel—Danazol—SHBG—breast cancer	8.91e-05	0.0303	CrCbGaD
Desogestrel—Nausea—Idarubicin—breast cancer	8.83e-05	0.0012	CcSEcCtD
Desogestrel—Gastrointestinal pain—Tamoxifen—breast cancer	8.76e-05	0.00119	CcSEcCtD
Desogestrel—Abdominal pain—Vinblastine—breast cancer	8.72e-05	0.00119	CcSEcCtD
Desogestrel—Fluid retention—Doxorubicin—breast cancer	8.68e-05	0.00118	CcSEcCtD
Desogestrel—Nervous system disorder—Thiotepa—breast cancer	8.58e-05	0.00117	CcSEcCtD
Desogestrel—Levonorgestrel—AR—breast cancer	8.58e-05	0.0292	CrCbGaD
Desogestrel—Urticaria—Tamoxifen—breast cancer	8.51e-05	0.00116	CcSEcCtD
Desogestrel—Skin disorder—Thiotepa—breast cancer	8.5e-05	0.00116	CcSEcCtD
Desogestrel—Norethindrone—PGR—breast cancer	8.48e-05	0.0289	CrCbGaD
Desogestrel—Abdominal pain—Tamoxifen—breast cancer	8.47e-05	0.00115	CcSEcCtD
Desogestrel—Gastrointestinal pain—Goserelin—breast cancer	8.37e-05	0.00114	CcSEcCtD
Desogestrel—Weight increased—Docetaxel—breast cancer	8.36e-05	0.00114	CcSEcCtD
Desogestrel—Urticaria—Melphalan—breast cancer	8.33e-05	0.00113	CcSEcCtD
Desogestrel—Weight decreased—Docetaxel—breast cancer	8.31e-05	0.00113	CcSEcCtD
Desogestrel—Neoplasm—Doxorubicin—breast cancer	8.26e-05	0.00113	CcSEcCtD
Desogestrel—Ethinyl Estradiol—SHBG—breast cancer	8.24e-05	0.0281	CrCbGaD
Desogestrel—Diarrhoea—Chlorambucil—breast cancer	8.23e-05	0.00112	CcSEcCtD
Desogestrel—Erythema multiforme—Paclitaxel—breast cancer	8.2e-05	0.00112	CcSEcCtD
Desogestrel—Urticaria—Goserelin—breast cancer	8.13e-05	0.00111	CcSEcCtD
Desogestrel—Hypersensitivity—Vinblastine—breast cancer	8.12e-05	0.00111	CcSEcCtD
Desogestrel—Eye disorder—Paclitaxel—breast cancer	8.11e-05	0.0011	CcSEcCtD
Desogestrel—Weight increased—Capecitabine—breast cancer	8.1e-05	0.0011	CcSEcCtD
Desogestrel—Abdominal pain—Goserelin—breast cancer	8.09e-05	0.0011	CcSEcCtD
Desogestrel—Weight decreased—Capecitabine—breast cancer	8.05e-05	0.0011	CcSEcCtD
Desogestrel—Hypertension—Irinotecan—breast cancer	8e-05	0.00109	CcSEcCtD
Desogestrel—Hypertension—Mitoxantrone—breast cancer	8e-05	0.00109	CcSEcCtD
Desogestrel—Norethindrone—SHBG—breast cancer	7.93e-05	0.027	CrCbGaD
Desogestrel—Gastrointestinal disorder—Vinorelbine—breast cancer	7.91e-05	0.00108	CcSEcCtD
Desogestrel—Hypersensitivity—Tamoxifen—breast cancer	7.89e-05	0.00107	CcSEcCtD
Desogestrel—Immune system disorder—Paclitaxel—breast cancer	7.84e-05	0.00107	CcSEcCtD
Desogestrel—Danazol—AR—breast cancer	7.81e-05	0.0266	CrCbGaD
Desogestrel—Hypertension—Gemcitabine—breast cancer	7.79e-05	0.00106	CcSEcCtD
Desogestrel—Hypersensitivity—Melphalan—breast cancer	7.73e-05	0.00105	CcSEcCtD
Desogestrel—Alopecia—Paclitaxel—breast cancer	7.67e-05	0.00104	CcSEcCtD
Desogestrel—Vomiting—Chlorambucil—breast cancer	7.65e-05	0.00104	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—breast cancer	7.63e-05	0.00104	CcSEcCtD
Desogestrel—Mental disorder—Paclitaxel—breast cancer	7.6e-05	0.00104	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Thiotepa—breast cancer	7.56e-05	0.00103	CcSEcCtD
Desogestrel—Malnutrition—Paclitaxel—breast cancer	7.55e-05	0.00103	CcSEcCtD
Desogestrel—Diarrhoea—Vinblastine—breast cancer	7.55e-05	0.00103	CcSEcCtD
Desogestrel—Hypersensitivity—Goserelin—breast cancer	7.54e-05	0.00103	CcSEcCtD
Desogestrel—Gastrointestinal pain—Vinorelbine—breast cancer	7.49e-05	0.00102	CcSEcCtD
Desogestrel—Nervous system disorder—Irinotecan—breast cancer	7.41e-05	0.00101	CcSEcCtD
Desogestrel—Skin disorder—Mitoxantrone—breast cancer	7.34e-05	0.001	CcSEcCtD
Desogestrel—Diarrhoea—Tamoxifen—breast cancer	7.33e-05	0.000998	CcSEcCtD
Desogestrel—Urticaria—Vinorelbine—breast cancer	7.28e-05	0.000991	CcSEcCtD
Desogestrel—Mood swings—Methotrexate—breast cancer	7.26e-05	0.000988	CcSEcCtD
Desogestrel—Abdominal pain—Vinorelbine—breast cancer	7.24e-05	0.000987	CcSEcCtD
Desogestrel—Nervous system disorder—Gemcitabine—breast cancer	7.22e-05	0.000983	CcSEcCtD
Desogestrel—Levonorgestrel—CYP19A1—breast cancer	7.18e-05	0.0245	CrCbGaD
Desogestrel—Diarrhoea—Melphalan—breast cancer	7.18e-05	0.000977	CcSEcCtD
Desogestrel—Gastrointestinal pain—Thiotepa—breast cancer	7.16e-05	0.000975	CcSEcCtD
Desogestrel—Skin disorder—Gemcitabine—breast cancer	7.15e-05	0.000974	CcSEcCtD
Desogestrel—Nausea—Chlorambucil—breast cancer	7.15e-05	0.000973	CcSEcCtD
Desogestrel—Nervous system disorder—Fluorouracil—breast cancer	7.1e-05	0.000967	CcSEcCtD
Desogestrel—Migraine—Epirubicin—breast cancer	7.06e-05	0.000961	CcSEcCtD
Desogestrel—Affect lability—Epirubicin—breast cancer	7.06e-05	0.000961	CcSEcCtD
Desogestrel—Vomiting—Vinblastine—breast cancer	7.01e-05	0.000955	CcSEcCtD
Desogestrel—Diarrhoea—Goserelin—breast cancer	7e-05	0.000953	CcSEcCtD
Desogestrel—Erythema multiforme—Docetaxel—breast cancer	6.95e-05	0.000947	CcSEcCtD
Desogestrel—Urticaria—Thiotepa—breast cancer	6.95e-05	0.000947	CcSEcCtD
Desogestrel—Breast disorder—Methotrexate—breast cancer	6.92e-05	0.000943	CcSEcCtD
Desogestrel—Abdominal pain—Thiotepa—breast cancer	6.92e-05	0.000942	CcSEcCtD
Desogestrel—Headache—Vinblastine—breast cancer	6.91e-05	0.000941	CcSEcCtD
Desogestrel—Eye disorder—Docetaxel—breast cancer	6.87e-05	0.000936	CcSEcCtD
Desogestrel—Vomiting—Tamoxifen—breast cancer	6.81e-05	0.000928	CcSEcCtD
Desogestrel—Mood swings—Epirubicin—breast cancer	6.79e-05	0.000925	CcSEcCtD
Desogestrel—Rash—Tamoxifen—breast cancer	6.75e-05	0.00092	CcSEcCtD
Desogestrel—Hypersensitivity—Vinorelbine—breast cancer	6.75e-05	0.000919	CcSEcCtD
Desogestrel—Dermatitis—Tamoxifen—breast cancer	6.75e-05	0.000919	CcSEcCtD
Desogestrel—Erythema multiforme—Capecitabine—breast cancer	6.73e-05	0.000917	CcSEcCtD
Desogestrel—Headache—Tamoxifen—breast cancer	6.71e-05	0.000914	CcSEcCtD
Desogestrel—Vomiting—Melphalan—breast cancer	6.67e-05	0.000908	CcSEcCtD
Desogestrel—Eye disorder—Capecitabine—breast cancer	6.65e-05	0.000906	CcSEcCtD
Desogestrel—Immune system disorder—Docetaxel—breast cancer	6.64e-05	0.000905	CcSEcCtD
Desogestrel—Rash—Melphalan—breast cancer	6.61e-05	0.000901	CcSEcCtD
Desogestrel—Levonorgestrel—ESR1—breast cancer	6.61e-05	0.0225	CrCbGaD
Desogestrel—Dermatitis—Melphalan—breast cancer	6.61e-05	0.0009	CcSEcCtD
Desogestrel—Nausea—Vinblastine—breast cancer	6.55e-05	0.000892	CcSEcCtD
Desogestrel—Danazol—CYP19A1—breast cancer	6.54e-05	0.0223	CrCbGaD
Desogestrel—Migraine—Doxorubicin—breast cancer	6.53e-05	0.000889	CcSEcCtD
Desogestrel—Affect lability—Doxorubicin—breast cancer	6.53e-05	0.000889	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Irinotecan—breast cancer	6.53e-05	0.000889	CcSEcCtD
Desogestrel—Hypertension—Paclitaxel—breast cancer	6.52e-05	0.000888	CcSEcCtD
Desogestrel—Vomiting—Goserelin—breast cancer	6.51e-05	0.000886	CcSEcCtD
Desogestrel—Alopecia—Docetaxel—breast cancer	6.5e-05	0.000885	CcSEcCtD
Desogestrel—Breast disorder—Epirubicin—breast cancer	6.48e-05	0.000882	CcSEcCtD
Desogestrel—Rash—Goserelin—breast cancer	6.45e-05	0.000879	CcSEcCtD
Desogestrel—Hypersensitivity—Thiotepa—breast cancer	6.45e-05	0.000878	CcSEcCtD
Desogestrel—Dermatitis—Goserelin—breast cancer	6.45e-05	0.000878	CcSEcCtD
Desogestrel—Mental disorder—Docetaxel—breast cancer	6.44e-05	0.000877	CcSEcCtD
Desogestrel—Immune system disorder—Capecitabine—breast cancer	6.43e-05	0.000876	CcSEcCtD
Desogestrel—Headache—Goserelin—breast cancer	6.41e-05	0.000873	CcSEcCtD
Desogestrel—Malnutrition—Docetaxel—breast cancer	6.4e-05	0.000872	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	6.39e-05	0.00087	CcSEcCtD
Desogestrel—Nausea—Tamoxifen—breast cancer	6.36e-05	0.000867	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Gemcitabine—breast cancer	6.36e-05	0.000866	CcSEcCtD
Desogestrel—Alopecia—Capecitabine—breast cancer	6.29e-05	0.000857	CcSEcCtD
Desogestrel—Mood swings—Doxorubicin—breast cancer	6.28e-05	0.000856	CcSEcCtD
Desogestrel—Diarrhoea—Vinorelbine—breast cancer	6.27e-05	0.000854	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Fluorouracil—breast cancer	6.25e-05	0.000851	CcSEcCtD
Desogestrel—Mental disorder—Capecitabine—breast cancer	6.24e-05	0.000849	CcSEcCtD
Desogestrel—Nausea—Melphalan—breast cancer	6.23e-05	0.000848	CcSEcCtD
Desogestrel—Malnutrition—Capecitabine—breast cancer	6.2e-05	0.000844	CcSEcCtD
Desogestrel—Gastrointestinal pain—Mitoxantrone—breast cancer	6.18e-05	0.000842	CcSEcCtD
Desogestrel—Gastrointestinal pain—Irinotecan—breast cancer	6.18e-05	0.000842	CcSEcCtD
Desogestrel—Allylestrenol—CYP3A4—breast cancer	6.12e-05	0.0208	CrCbGaD
Desogestrel—Nausea—Goserelin—breast cancer	6.08e-05	0.000828	CcSEcCtD
Desogestrel—Nervous system disorder—Paclitaxel—breast cancer	6.05e-05	0.000823	CcSEcCtD
Desogestrel—Danazol—ESR1—breast cancer	6.02e-05	0.0205	CrCbGaD
Desogestrel—Urticaria—Mitoxantrone—breast cancer	6e-05	0.000818	CcSEcCtD
Desogestrel—Breast disorder—Doxorubicin—breast cancer	6e-05	0.000816	CcSEcCtD
Desogestrel—Diarrhoea—Thiotepa—breast cancer	5.99e-05	0.000815	CcSEcCtD
Desogestrel—Skin disorder—Paclitaxel—breast cancer	5.99e-05	0.000815	CcSEcCtD
Desogestrel—Abdominal pain—Irinotecan—breast cancer	5.97e-05	0.000814	CcSEcCtD
Desogestrel—Abdominal pain—Mitoxantrone—breast cancer	5.97e-05	0.000814	CcSEcCtD
Desogestrel—Vomiting—Vinorelbine—breast cancer	5.83e-05	0.000793	CcSEcCtD
Desogestrel—Rash—Vinorelbine—breast cancer	5.78e-05	0.000787	CcSEcCtD
Desogestrel—Dermatitis—Vinorelbine—breast cancer	5.77e-05	0.000786	CcSEcCtD
Desogestrel—Urticaria—Fluorouracil—breast cancer	5.75e-05	0.000783	CcSEcCtD
Desogestrel—Headache—Vinorelbine—breast cancer	5.74e-05	0.000782	CcSEcCtD
Desogestrel—Weight increased—Epirubicin—breast cancer	5.64e-05	0.000768	CcSEcCtD
Desogestrel—Weight decreased—Epirubicin—breast cancer	5.61e-05	0.000763	CcSEcCtD
Desogestrel—Ethinyl Estradiol—ESR1—breast cancer	5.57e-05	0.019	CrCbGaD
Desogestrel—Hypersensitivity—Mitoxantrone—breast cancer	5.57e-05	0.000758	CcSEcCtD
Desogestrel—Hypersensitivity—Irinotecan—breast cancer	5.57e-05	0.000758	CcSEcCtD
Desogestrel—Vomiting—Thiotepa—breast cancer	5.56e-05	0.000758	CcSEcCtD
Desogestrel—Hypertension—Docetaxel—breast cancer	5.53e-05	0.000753	CcSEcCtD
Desogestrel—Rash—Thiotepa—breast cancer	5.52e-05	0.000751	CcSEcCtD
Desogestrel—Dermatitis—Thiotepa—breast cancer	5.51e-05	0.000751	CcSEcCtD
Desogestrel—Headache—Thiotepa—breast cancer	5.48e-05	0.000747	CcSEcCtD
Desogestrel—Nausea—Vinorelbine—breast cancer	5.44e-05	0.000741	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	5.41e-05	0.000737	CcSEcCtD
Desogestrel—Hypertension—Capecitabine—breast cancer	5.35e-05	0.000729	CcSEcCtD
Desogestrel—Hypersensitivity—Fluorouracil—breast cancer	5.33e-05	0.000726	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Paclitaxel—breast cancer	5.32e-05	0.000725	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	5.24e-05	0.000714	CcSEcCtD
Desogestrel—Weight increased—Doxorubicin—breast cancer	5.22e-05	0.000711	CcSEcCtD
Desogestrel—Nausea—Thiotepa—breast cancer	5.2e-05	0.000708	CcSEcCtD
Desogestrel—Weight decreased—Doxorubicin—breast cancer	5.19e-05	0.000706	CcSEcCtD
Desogestrel—Diarrhoea—Irinotecan—breast cancer	5.17e-05	0.000704	CcSEcCtD
Desogestrel—Diarrhoea—Mitoxantrone—breast cancer	5.17e-05	0.000704	CcSEcCtD
Desogestrel—Nervous system disorder—Docetaxel—breast cancer	5.12e-05	0.000698	CcSEcCtD
Desogestrel—Skin disorder—Docetaxel—breast cancer	5.07e-05	0.000691	CcSEcCtD
Desogestrel—Gastrointestinal pain—Paclitaxel—breast cancer	5.04e-05	0.000686	CcSEcCtD
Desogestrel—Diarrhoea—Gemcitabine—breast cancer	5.04e-05	0.000686	CcSEcCtD
Desogestrel—Erythema multiforme—Methotrexate—breast cancer	5.01e-05	0.000682	CcSEcCtD
Desogestrel—Nervous system disorder—Capecitabine—breast cancer	4.96e-05	0.000676	CcSEcCtD
Desogestrel—Eye disorder—Methotrexate—breast cancer	4.95e-05	0.000675	CcSEcCtD
Desogestrel—Diarrhoea—Fluorouracil—breast cancer	4.95e-05	0.000674	CcSEcCtD
Desogestrel—Skin disorder—Capecitabine—breast cancer	4.91e-05	0.000669	CcSEcCtD
Desogestrel—Urticaria—Paclitaxel—breast cancer	4.9e-05	0.000667	CcSEcCtD
Desogestrel—Abdominal pain—Paclitaxel—breast cancer	4.87e-05	0.000664	CcSEcCtD
Desogestrel—Vomiting—Mitoxantrone—breast cancer	4.81e-05	0.000654	CcSEcCtD
Desogestrel—Vomiting—Irinotecan—breast cancer	4.81e-05	0.000654	CcSEcCtD
Desogestrel—Immune system disorder—Methotrexate—breast cancer	4.79e-05	0.000652	CcSEcCtD
Desogestrel—Etonogestrel—CYP3A4—breast cancer	4.77e-05	0.0162	CrCbGaD
Desogestrel—Rash—Irinotecan—breast cancer	4.77e-05	0.000649	CcSEcCtD
Desogestrel—Rash—Mitoxantrone—breast cancer	4.77e-05	0.000649	CcSEcCtD
Desogestrel—Dermatitis—Mitoxantrone—breast cancer	4.76e-05	0.000648	CcSEcCtD
Desogestrel—Dermatitis—Irinotecan—breast cancer	4.76e-05	0.000648	CcSEcCtD
Desogestrel—Headache—Irinotecan—breast cancer	4.73e-05	0.000645	CcSEcCtD
Desogestrel—Headache—Mitoxantrone—breast cancer	4.73e-05	0.000645	CcSEcCtD
Desogestrel—Erythema multiforme—Epirubicin—breast cancer	4.69e-05	0.000639	CcSEcCtD
Desogestrel—Alopecia—Methotrexate—breast cancer	4.68e-05	0.000638	CcSEcCtD
Desogestrel—Vomiting—Gemcitabine—breast cancer	4.68e-05	0.000637	CcSEcCtD
Desogestrel—Mental disorder—Methotrexate—breast cancer	4.64e-05	0.000632	CcSEcCtD
Desogestrel—Rash—Gemcitabine—breast cancer	4.64e-05	0.000632	CcSEcCtD
Desogestrel—Dermatitis—Gemcitabine—breast cancer	4.64e-05	0.000632	CcSEcCtD
Desogestrel—Eye disorder—Epirubicin—breast cancer	4.64e-05	0.000631	CcSEcCtD
Desogestrel—Malnutrition—Methotrexate—breast cancer	4.61e-05	0.000628	CcSEcCtD
Desogestrel—Headache—Gemcitabine—breast cancer	4.61e-05	0.000628	CcSEcCtD
Desogestrel—Vomiting—Fluorouracil—breast cancer	4.6e-05	0.000627	CcSEcCtD
Desogestrel—Rash—Fluorouracil—breast cancer	4.56e-05	0.000622	CcSEcCtD
Desogestrel—Dermatitis—Fluorouracil—breast cancer	4.56e-05	0.000621	CcSEcCtD
Desogestrel—Hypersensitivity—Paclitaxel—breast cancer	4.54e-05	0.000618	CcSEcCtD
Desogestrel—Headache—Fluorouracil—breast cancer	4.53e-05	0.000618	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Docetaxel—breast cancer	4.51e-05	0.000614	CcSEcCtD
Desogestrel—Nausea—Irinotecan—breast cancer	4.49e-05	0.000611	CcSEcCtD
Desogestrel—Nausea—Mitoxantrone—breast cancer	4.49e-05	0.000611	CcSEcCtD
Desogestrel—Immune system disorder—Epirubicin—breast cancer	4.48e-05	0.00061	CcSEcCtD
Desogestrel—Alopecia—Epirubicin—breast cancer	4.38e-05	0.000597	CcSEcCtD
Desogestrel—Nausea—Gemcitabine—breast cancer	4.37e-05	0.000596	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Capecitabine—breast cancer	4.37e-05	0.000595	CcSEcCtD
Desogestrel—Mental disorder—Epirubicin—breast cancer	4.35e-05	0.000592	CcSEcCtD
Desogestrel—Erythema multiforme—Doxorubicin—breast cancer	4.34e-05	0.000591	CcSEcCtD
Desogestrel—Malnutrition—Epirubicin—breast cancer	4.32e-05	0.000588	CcSEcCtD
Desogestrel—Nausea—Fluorouracil—breast cancer	4.3e-05	0.000586	CcSEcCtD
Desogestrel—Eye disorder—Doxorubicin—breast cancer	4.29e-05	0.000584	CcSEcCtD
Desogestrel—Gastrointestinal pain—Docetaxel—breast cancer	4.27e-05	0.000582	CcSEcCtD
Desogestrel—Diarrhoea—Paclitaxel—breast cancer	4.22e-05	0.000574	CcSEcCtD
Desogestrel—Immune system disorder—Doxorubicin—breast cancer	4.15e-05	0.000565	CcSEcCtD
Desogestrel—Gastrointestinal pain—Capecitabine—breast cancer	4.14e-05	0.000563	CcSEcCtD
Desogestrel—Abdominal pain—Docetaxel—breast cancer	4.13e-05	0.000562	CcSEcCtD
Desogestrel—Alopecia—Doxorubicin—breast cancer	4.06e-05	0.000552	CcSEcCtD
Desogestrel—Mental disorder—Doxorubicin—breast cancer	4.02e-05	0.000548	CcSEcCtD
Desogestrel—Urticaria—Capecitabine—breast cancer	4.02e-05	0.000547	CcSEcCtD
Desogestrel—Abdominal pain—Capecitabine—breast cancer	4e-05	0.000545	CcSEcCtD
Desogestrel—Malnutrition—Doxorubicin—breast cancer	4e-05	0.000544	CcSEcCtD
Desogestrel—Vomiting—Paclitaxel—breast cancer	3.92e-05	0.000534	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	3.9e-05	0.000531	CcSEcCtD
Desogestrel—Rash—Paclitaxel—breast cancer	3.89e-05	0.000529	CcSEcCtD
Desogestrel—Dermatitis—Paclitaxel—breast cancer	3.88e-05	0.000529	CcSEcCtD
Desogestrel—Headache—Paclitaxel—breast cancer	3.86e-05	0.000526	CcSEcCtD
Desogestrel—Hypersensitivity—Docetaxel—breast cancer	3.85e-05	0.000524	CcSEcCtD
Desogestrel—Hypertension—Epirubicin—breast cancer	3.73e-05	0.000508	CcSEcCtD
Desogestrel—Hypersensitivity—Capecitabine—breast cancer	3.73e-05	0.000508	CcSEcCtD
Desogestrel—Nervous system disorder—Methotrexate—breast cancer	3.69e-05	0.000503	CcSEcCtD
Desogestrel—Nausea—Paclitaxel—breast cancer	3.66e-05	0.000499	CcSEcCtD
Desogestrel—Skin disorder—Methotrexate—breast cancer	3.66e-05	0.000498	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	3.65e-05	0.000497	CcSEcCtD
Desogestrel—Diarrhoea—Docetaxel—breast cancer	3.57e-05	0.000487	CcSEcCtD
Desogestrel—Diarrhoea—Capecitabine—breast cancer	3.46e-05	0.000471	CcSEcCtD
Desogestrel—Nervous system disorder—Epirubicin—breast cancer	3.46e-05	0.000471	CcSEcCtD
Desogestrel—Hypertension—Doxorubicin—breast cancer	3.45e-05	0.00047	CcSEcCtD
Desogestrel—Skin disorder—Epirubicin—breast cancer	3.42e-05	0.000466	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	3.38e-05	0.00046	CcSEcCtD
Desogestrel—Levonorgestrel—CYP3A4—breast cancer	3.37e-05	0.0115	CrCbGaD
Desogestrel—Vomiting—Docetaxel—breast cancer	3.32e-05	0.000452	CcSEcCtD
Desogestrel—Rash—Docetaxel—breast cancer	3.29e-05	0.000449	CcSEcCtD
Desogestrel—Dermatitis—Docetaxel—breast cancer	3.29e-05	0.000448	CcSEcCtD
Desogestrel—Headache—Docetaxel—breast cancer	3.27e-05	0.000446	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Methotrexate—breast cancer	3.25e-05	0.000443	CcSEcCtD
Desogestrel—Vomiting—Capecitabine—breast cancer	3.22e-05	0.000438	CcSEcCtD
Desogestrel—Nervous system disorder—Doxorubicin—breast cancer	3.2e-05	0.000435	CcSEcCtD
Desogestrel—Rash—Capecitabine—breast cancer	3.19e-05	0.000434	CcSEcCtD
Desogestrel—Dermatitis—Capecitabine—breast cancer	3.19e-05	0.000434	CcSEcCtD
Desogestrel—Headache—Capecitabine—breast cancer	3.17e-05	0.000432	CcSEcCtD
Desogestrel—Skin disorder—Doxorubicin—breast cancer	3.17e-05	0.000431	CcSEcCtD
Desogestrel—Nausea—Docetaxel—breast cancer	3.1e-05	0.000423	CcSEcCtD
Desogestrel—Gastrointestinal pain—Methotrexate—breast cancer	3.08e-05	0.000419	CcSEcCtD
Desogestrel—Danazol—CYP3A4—breast cancer	3.07e-05	0.0105	CrCbGaD
Desogestrel—Gastrointestinal disorder—Epirubicin—breast cancer	3.04e-05	0.000414	CcSEcCtD
Desogestrel—Nausea—Capecitabine—breast cancer	3e-05	0.000409	CcSEcCtD
Desogestrel—Urticaria—Methotrexate—breast cancer	2.99e-05	0.000407	CcSEcCtD
Desogestrel—Abdominal pain—Methotrexate—breast cancer	2.98e-05	0.000405	CcSEcCtD
Desogestrel—Gastrointestinal pain—Epirubicin—breast cancer	2.88e-05	0.000392	CcSEcCtD
Desogestrel—Ethinyl Estradiol—CYP3A4—breast cancer	2.84e-05	0.00968	CrCbGaD
Desogestrel—Gastrointestinal disorder—Doxorubicin—breast cancer	2.82e-05	0.000383	CcSEcCtD
Desogestrel—Urticaria—Epirubicin—breast cancer	2.8e-05	0.000381	CcSEcCtD
Desogestrel—Abdominal pain—Epirubicin—breast cancer	2.79e-05	0.000379	CcSEcCtD
Desogestrel—Hypersensitivity—Methotrexate—breast cancer	2.77e-05	0.000378	CcSEcCtD
Desogestrel—Norethindrone—CYP3A4—breast cancer	2.73e-05	0.00931	CrCbGaD
Desogestrel—Gastrointestinal pain—Doxorubicin—breast cancer	2.67e-05	0.000363	CcSEcCtD
Desogestrel—Hypersensitivity—Epirubicin—breast cancer	2.6e-05	0.000354	CcSEcCtD
Desogestrel—Urticaria—Doxorubicin—breast cancer	2.59e-05	0.000353	CcSEcCtD
Desogestrel—Abdominal pain—Doxorubicin—breast cancer	2.58e-05	0.000351	CcSEcCtD
Desogestrel—Diarrhoea—Methotrexate—breast cancer	2.58e-05	0.000351	CcSEcCtD
Desogestrel—Diarrhoea—Epirubicin—breast cancer	2.41e-05	0.000328	CcSEcCtD
Desogestrel—Hypersensitivity—Doxorubicin—breast cancer	2.4e-05	0.000327	CcSEcCtD
Desogestrel—Vomiting—Methotrexate—breast cancer	2.39e-05	0.000326	CcSEcCtD
Desogestrel—Norethindrone—ALB—breast cancer	2.38e-05	0.00812	CrCbGaD
Desogestrel—Rash—Methotrexate—breast cancer	2.37e-05	0.000323	CcSEcCtD
Desogestrel—Dermatitis—Methotrexate—breast cancer	2.37e-05	0.000323	CcSEcCtD
Desogestrel—Ethinyl Estradiol—ABCB1—breast cancer	2.37e-05	0.00806	CrCbGaD
Desogestrel—Headache—Methotrexate—breast cancer	2.36e-05	0.000321	CcSEcCtD
Desogestrel—Norethindrone—ABCB1—breast cancer	2.27e-05	0.00775	CrCbGaD
Desogestrel—Vomiting—Epirubicin—breast cancer	2.24e-05	0.000305	CcSEcCtD
Desogestrel—Nausea—Methotrexate—breast cancer	2.24e-05	0.000305	CcSEcCtD
Desogestrel—Diarrhoea—Doxorubicin—breast cancer	2.23e-05	0.000304	CcSEcCtD
Desogestrel—Rash—Epirubicin—breast cancer	2.22e-05	0.000303	CcSEcCtD
Desogestrel—Dermatitis—Epirubicin—breast cancer	2.22e-05	0.000302	CcSEcCtD
Desogestrel—Headache—Epirubicin—breast cancer	2.21e-05	0.000301	CcSEcCtD
Desogestrel—Nausea—Epirubicin—breast cancer	2.09e-05	0.000285	CcSEcCtD
Desogestrel—Vomiting—Doxorubicin—breast cancer	2.07e-05	0.000282	CcSEcCtD
Desogestrel—Rash—Doxorubicin—breast cancer	2.06e-05	0.00028	CcSEcCtD
Desogestrel—Dermatitis—Doxorubicin—breast cancer	2.05e-05	0.00028	CcSEcCtD
Desogestrel—Headache—Doxorubicin—breast cancer	2.04e-05	0.000278	CcSEcCtD
Desogestrel—Nausea—Doxorubicin—breast cancer	1.94e-05	0.000264	CcSEcCtD
Desogestrel—ESR1—Generic Transcription Pathway—NOTCH1—breast cancer	9.98e-06	0.000193	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—GLI2—breast cancer	9.8e-06	0.00019	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—VCP—breast cancer	9.8e-06	0.00019	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—FLT1—breast cancer	9.8e-06	0.00019	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—IL6—breast cancer	9.76e-06	0.000189	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—FGF3—breast cancer	9.75e-06	0.000189	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—SQSTM1—breast cancer	9.75e-06	0.000189	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—HSPA1B—breast cancer	9.71e-06	0.000188	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—LEPR—breast cancer	9.64e-06	0.000187	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—JAG1—breast cancer	9.63e-06	0.000187	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—PARP1—breast cancer	9.59e-06	0.000186	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—NOTCH3—breast cancer	9.59e-06	0.000186	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—CALCA—breast cancer	9.47e-06	0.000184	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—RPS6—breast cancer	9.36e-06	0.000181	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—PGR—breast cancer	9.31e-06	0.00018	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—FGF4—breast cancer	9.29e-06	0.00018	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—CXCR4—breast cancer	9.25e-06	0.000179	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—CXCL12—breast cancer	9.25e-06	0.000179	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	9.18e-06	0.000178	CbGpPWpGaD
Desogestrel—PGR—Generic Transcription Pathway—MYC—breast cancer	9.15e-06	0.000177	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—DNMT1—breast cancer	9.13e-06	0.000177	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—PAK1—breast cancer	9.08e-06	0.000176	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—AKT1—breast cancer	9.05e-06	0.000175	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—AKT1—breast cancer	9e-06	0.000174	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—NCOA2—breast cancer	8.96e-06	0.000174	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—ARHGDIA—breast cancer	8.96e-06	0.000174	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—TCF7L2—breast cancer	8.92e-06	0.000173	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	8.88e-06	0.000172	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—EZH2—breast cancer	8.84e-06	0.000171	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—FST—breast cancer	8.73e-06	0.000169	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—NOTCH3—breast cancer	8.65e-06	0.000168	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—PARP1—breast cancer	8.65e-06	0.000168	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—HEY2—breast cancer	8.63e-06	0.000167	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—HSP90AA1—breast cancer	8.6e-06	0.000167	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—NOTCH2—breast cancer	8.6e-06	0.000167	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—RPS6KB2—breast cancer	8.52e-06	0.000165	CbGpPWpGaD
Desogestrel—ESR1—Generic Transcription Pathway—SERPINE1—breast cancer	8.49e-06	0.000164	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—ESR1—breast cancer	8.47e-06	0.000164	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—RPS6—breast cancer	8.45e-06	0.000164	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—RGS2—breast cancer	8.43e-06	0.000163	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—PRL—breast cancer	8.37e-06	0.000162	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—AGTR1—breast cancer	8.37e-06	0.000162	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CCL20—breast cancer	8.33e-06	0.000161	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—ADAM10—breast cancer	8.24e-06	0.00016	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—STK11—breast cancer	8.24e-06	0.00016	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—ESR2—breast cancer	8.2e-06	0.000159	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—NOTCH1—breast cancer	8.19e-06	0.000159	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—PLG—breast cancer	8.15e-06	0.000158	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—LPAR1—breast cancer	8.07e-06	0.000156	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—TLE3—breast cancer	8.07e-06	0.000156	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—FGF10—breast cancer	8.02e-06	0.000155	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—HEY1—breast cancer	7.99e-06	0.000155	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—DLL1—breast cancer	7.83e-06	0.000152	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—NOTCH2—breast cancer	7.76e-06	0.00015	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—PDGFA—breast cancer	7.74e-06	0.00015	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—HIST1H2BK—breast cancer	7.69e-06	0.000149	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—HIST1H2BC—breast cancer	7.69e-06	0.000149	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—TGFBR2—breast cancer	7.63e-06	0.000148	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—GRB7—breast cancer	7.62e-06	0.000148	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PDE4D—breast cancer	7.62e-06	0.000148	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—NCOA1—breast cancer	7.55e-06	0.000146	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—ITPR1—breast cancer	7.51e-06	0.000145	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	7.5e-06	0.000145	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—TAB2—breast cancer	7.49e-06	0.000145	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—ERBB4—breast cancer	7.46e-06	0.000145	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—STAT5A—breast cancer	7.46e-06	0.000145	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—MMP3—breast cancer	7.46e-06	0.000145	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CNR2—breast cancer	7.43e-06	0.000144	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—DKK1—breast cancer	7.25e-06	0.00014	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—AR—breast cancer	7.24e-06	0.00014	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—SMAD4—breast cancer	7.22e-06	0.00014	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—VEGFC—breast cancer	7.19e-06	0.000139	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—IGF1R—breast cancer	7.18e-06	0.000139	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—JAG2—breast cancer	7.08e-06	0.000137	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—HES1—breast cancer	7.05e-06	0.000137	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—PLA2G4A—breast cancer	7.01e-06	0.000136	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—NCOR1—breast cancer	7.01e-06	0.000136	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—WNT1—breast cancer	6.98e-06	0.000135	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—SERPINE1—breast cancer	6.96e-06	0.000135	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—FGF1—breast cancer	6.93e-06	0.000134	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—CSF2—breast cancer	6.93e-06	0.000134	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—NRG1—breast cancer	6.88e-06	0.000133	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—H2AFX—breast cancer	6.83e-06	0.000132	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—E2F1—breast cancer	6.78e-06	0.000131	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—NOTCH4—breast cancer	6.62e-06	0.000128	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—SIRT1—breast cancer	6.6e-06	0.000128	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—GZMB—breast cancer	6.58e-06	0.000127	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—SMAD4—breast cancer	6.52e-06	0.000126	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—SPP1—breast cancer	6.52e-06	0.000126	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—VDR—breast cancer	6.51e-06	0.000126	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—ERBB3—breast cancer	6.45e-06	0.000125	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—FGFR2—breast cancer	6.44e-06	0.000125	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CXCL2—breast cancer	6.39e-06	0.000124	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—AGTR2—breast cancer	6.39e-06	0.000124	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—NCOR1—breast cancer	6.33e-06	0.000123	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PTHLH—breast cancer	6.31e-06	0.000122	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—BMP2—breast cancer	6.31e-06	0.000122	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—TERT—breast cancer	6.18e-06	0.00012	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—H2AFX—breast cancer	6.17e-06	0.00012	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—EDNRB—breast cancer	6.11e-06	0.000119	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PGR—breast cancer	6.05e-06	0.000117	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—THBS1—breast cancer	6.02e-06	0.000117	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—FGFR1—breast cancer	6e-06	0.000116	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—ERCC2—breast cancer	5.95e-06	0.000115	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—HIF1A—breast cancer	5.91e-06	0.000115	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—LEP—breast cancer	5.77e-06	0.000112	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—FLT1—breast cancer	5.75e-06	0.000111	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—FGF3—breast cancer	5.72e-06	0.000111	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—SQSTM1—breast cancer	5.72e-06	0.000111	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—CAV1—breast cancer	5.71e-06	0.000111	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—KDR—breast cancer	5.65e-06	0.00011	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—JAG1—breast cancer	5.65e-06	0.00011	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PARP1—breast cancer	5.63e-06	0.000109	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—NOTCH3—breast cancer	5.63e-06	0.000109	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CALCA—breast cancer	5.56e-06	0.000108	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—ESR1—breast cancer	5.51e-06	0.000107	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—RPS6—breast cancer	5.49e-06	0.000106	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—FGF4—breast cancer	5.45e-06	0.000106	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—FN1—breast cancer	5.44e-06	0.000105	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CXCL12—breast cancer	5.43e-06	0.000105	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CXCR4—breast cancer	5.43e-06	0.000105	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—NFKBIA—breast cancer	5.37e-06	0.000104	CbGpPWpGaD
Desogestrel—ESR1—Generic Transcription Pathway—MYC—breast cancer	5.37e-06	0.000104	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PAK1—breast cancer	5.33e-06	0.000103	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—NOTCH1—breast cancer	5.32e-06	0.000103	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—TCF7L2—breast cancer	5.24e-06	0.000101	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—PIK3CG—breast cancer	5.21e-06	0.000101	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—APC—breast cancer	5.21e-06	0.000101	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—KIT—breast cancer	5.21e-06	0.000101	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—EGF—breast cancer	5.15e-06	9.97e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—HSP90AA1—breast cancer	5.05e-06	9.78e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—NOTCH2—breast cancer	5.05e-06	9.78e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—AGTR1—breast cancer	4.91e-06	9.52e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PRL—breast cancer	4.91e-06	9.52e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—BRAF—breast cancer	4.89e-06	9.48e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—STK11—breast cancer	4.84e-06	9.38e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—ADAM10—breast cancer	4.84e-06	9.38e-05	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—NOTCH1—breast cancer	4.81e-06	9.31e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PLG—breast cancer	4.78e-06	9.27e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—IGF1—breast cancer	4.77e-06	9.24e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—AKT2—breast cancer	4.76e-06	9.23e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—FGF10—breast cancer	4.71e-06	9.12e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—PIK3CD—breast cancer	4.58e-06	8.87e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PDGFA—breast cancer	4.54e-06	8.8e-05	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—MAPK3—breast cancer	4.53e-06	8.78e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—SERPINE1—breast cancer	4.53e-06	8.77e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—TGFBR2—breast cancer	4.48e-06	8.68e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—ITPR1—breast cancer	4.41e-06	8.54e-05	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—MYC—breast cancer	4.41e-06	8.54e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—ERBB4—breast cancer	4.38e-06	8.48e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—MMP3—breast cancer	4.38e-06	8.48e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—STAT5A—breast cancer	4.38e-06	8.48e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—NOS3—breast cancer	4.32e-06	8.38e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—SMAD4—breast cancer	4.24e-06	8.21e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—IGF1R—breast cancer	4.21e-06	8.16e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—HES1—breast cancer	4.14e-06	8.02e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PLA2G4A—breast cancer	4.11e-06	7.97e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—NCOR1—breast cancer	4.11e-06	7.97e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—MDM2—breast cancer	4.1e-06	7.95e-05	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—SERPINE1—breast cancer	4.09e-06	7.92e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—RAF1—breast cancer	4.09e-06	7.92e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CSF2—breast cancer	4.07e-06	7.89e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—FGF1—breast cancer	4.07e-06	7.89e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—RELA—breast cancer	4.07e-06	7.88e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—ERBB2—breast cancer	4.04e-06	7.83e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—NRG1—breast cancer	4.04e-06	7.83e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—H2AFX—breast cancer	4.01e-06	7.77e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—PIK3CB—breast cancer	3.99e-06	7.73e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—MTOR—breast cancer	3.99e-06	7.73e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—E2F1—breast cancer	3.98e-06	7.72e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—CXCL8—breast cancer	3.83e-06	7.43e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—SPP1—breast cancer	3.83e-06	7.41e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—ERBB3—breast cancer	3.78e-06	7.33e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—FGFR2—breast cancer	3.78e-06	7.32e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—CDKN1B—breast cancer	3.74e-06	7.25e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—CASP3—breast cancer	3.67e-06	7.11e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—IL2—breast cancer	3.66e-06	7.1e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—TERT—breast cancer	3.63e-06	7.03e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—CCND1—breast cancer	3.57e-06	6.92e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—JUN—breast cancer	3.56e-06	6.91e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—CTNNB1—breast cancer	3.54e-06	6.85e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—FGFR1—breast cancer	3.52e-06	6.82e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—HIF1A—breast cancer	3.47e-06	6.72e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—MMP9—breast cancer	3.47e-06	6.72e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—CDKN1A—breast cancer	3.45e-06	6.7e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—PTEN—breast cancer	3.45e-06	6.68e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—LEP—breast cancer	3.39e-06	6.56e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—MAPK8—breast cancer	3.37e-06	6.53e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CAV1—breast cancer	3.35e-06	6.5e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—KDR—breast cancer	3.32e-06	6.43e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—SRC—breast cancer	3.2e-06	6.2e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—FN1—breast cancer	3.19e-06	6.19e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—NFKBIA—breast cancer	3.15e-06	6.11e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—NOTCH1—breast cancer	3.12e-06	6.06e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—VEGFA—breast cancer	3.11e-06	6.03e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—STAT3—breast cancer	3.08e-06	5.97e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—KIT—breast cancer	3.06e-06	5.92e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PIK3CG—breast cancer	3.06e-06	5.92e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—APC—breast cancer	3.06e-06	5.92e-05	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—AKT1—breast cancer	3.06e-06	5.92e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—EGF—breast cancer	3.02e-06	5.85e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—MAPK3—breast cancer	2.95e-06	5.71e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—BRAF—breast cancer	2.87e-06	5.57e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—MYC—breast cancer	2.86e-06	5.55e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—TGFB1—breast cancer	2.86e-06	5.54e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—EGFR—breast cancer	2.8e-06	5.43e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—IGF1—breast cancer	2.8e-06	5.42e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—AKT2—breast cancer	2.8e-06	5.42e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PIK3CD—breast cancer	2.69e-06	5.21e-05	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—MAPK3—breast cancer	2.66e-06	5.15e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—SERPINE1—breast cancer	2.66e-06	5.15e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—KRAS—breast cancer	2.65e-06	5.13e-05	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—MYC—breast cancer	2.59e-06	5.01e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—NOS3—breast cancer	2.54e-06	4.92e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—PIK3CA—breast cancer	2.43e-06	4.71e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—MDM2—breast cancer	2.41e-06	4.66e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—RAF1—breast cancer	2.4e-06	4.65e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—RELA—breast cancer	2.39e-06	4.63e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—ERBB2—breast cancer	2.37e-06	4.6e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—TP53—breast cancer	2.35e-06	4.56e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PIK3CB—breast cancer	2.34e-06	4.54e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—MTOR—breast cancer	2.34e-06	4.54e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CXCL8—breast cancer	2.25e-06	4.36e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—HRAS—breast cancer	2.25e-06	4.36e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CDKN1B—breast cancer	2.2e-06	4.26e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CASP3—breast cancer	2.15e-06	4.17e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—IL6—breast cancer	2.15e-06	4.17e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—IL2—breast cancer	2.15e-06	4.17e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CCND1—breast cancer	2.1e-06	4.06e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—JUN—breast cancer	2.09e-06	4.05e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CTNNB1—breast cancer	2.08e-06	4.02e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—MMP9—breast cancer	2.03e-06	3.94e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CDKN1A—breast cancer	2.03e-06	3.93e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PTEN—breast cancer	2.02e-06	3.92e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—AKT1—breast cancer	1.99e-06	3.85e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—MAPK8—breast cancer	1.98e-06	3.84e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—SRC—breast cancer	1.88e-06	3.64e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—VEGFA—breast cancer	1.83e-06	3.54e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—STAT3—breast cancer	1.81e-06	3.51e-05	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—AKT1—breast cancer	1.79e-06	3.48e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—MAPK3—breast cancer	1.73e-06	3.35e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—MYC—breast cancer	1.68e-06	3.26e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—TGFB1—breast cancer	1.68e-06	3.25e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—EGFR—breast cancer	1.64e-06	3.19e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—KRAS—breast cancer	1.55e-06	3.01e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PIK3CA—breast cancer	1.43e-06	2.77e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—TP53—breast cancer	1.38e-06	2.68e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—HRAS—breast cancer	1.32e-06	2.56e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—IL6—breast cancer	1.26e-06	2.45e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—AKT1—breast cancer	1.17e-06	2.26e-05	CbGpPWpGaD
